logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On June 2, Sun Hung Kai Co. (00086) spent approximately 167,400 Hong Kong dollars to repurchase 40,000 shares.

date
17:17 02/06/2026
avatar
GMT Eight
New World Development Company Limited (00086) announced that on June 2, 2026, it spent approximately HK$167,400 to repurchase 40,000 shares.
SUN HUNG KAI CO (00086) announced that on June 2, 2026, it purchased approximately 40,000 shares for about 167,400 Hong Kong dollars.
Related Articles
HK Stock
CEB WATER(01857): "25 China Everbright Water MTNO03" will pay interest on June 9th.
US Stock
Bollore's 5.7 billion asset deals implicated in money laundering; Morgan Stanley (MS.US) and other institutions sued
China Stock
Zhejiang Ausun Pharmaceutical (603229.SH) has received the approval notice for the market application of Atorvastatin Sodium Active Pharmaceutical Ingredient.
CEB WATER(01857): "25 China Everbright Water MTNO03" will pay interest on June 9th.
HK Stock
Bollore's 5.7 billion asset deals implicated in money laundering; Morgan Stanley (MS.US) and other institutions sued
US Stock
Zhejiang Ausun Pharmaceutical (603229.SH) has received the approval notice for the market application of Atorvastatin Sodium Active Pharmaceutical Ingredient.
China Stock
RECOMMEND
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
Google Revamps Search and Launches Gemini 3.5 Flash to Strengthen AI Ecosystem
icon
21/05/2026
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
U.S. Threatens Renewed Strikes on Iran Amid Stalled Talks
icon
21/05/2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
IPOs, Market Surges, and Brain‑Computer Breakthroughs Dominate Securities Headlines — May 20, 2026
icon
21/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.